Limflow, Now Part Of Stryker

Limflow, Now Part Of Stryker company information, Employees & Contact Information

LimFlow SA, now part of Stryker, is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation.   LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.

Company Details

Employees
27
Founded
-
Address
6001 Oak Canyon, Irvine,california 92618,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Irvine, California
Looking for a particular Limflow, Now Part Of Stryker employee's phone or email?

Limflow, Now Part Of Stryker Questions

News

FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options - Diagnostic and Interventional Cardiology

FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options Diagnostic and Interventional Cardiology

Dr. Pedro Martinez-Clark, Founder of Amavita Heart and Vascular™, Partners with LimFlow®, an FDA Approved System for Chronic Limb-Threatening Ischemia Patients - Florida Hospital News and Healthcare Report

Dr. Pedro Martinez-Clark, Founder of Amavita Heart and Vascular™, Partners with LimFlow®, an FDA Approved System for Chronic Limb-Threatening Ischemia Patients Florida Hospital News and Healthcare Report

Watkins Advises Inari Medical in Acquisition of LimFlow - Latham & Watkins LLP

Watkins Advises Inari Medical in Acquisition of LimFlow Latham & Watkins LLP

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI - TCTMD.com

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI TCTMD.com

Inari Medical to buy limb-saving device maker LimFlow for up to $415M - MedTech Dive

Inari Medical to buy limb-saving device maker LimFlow for up to $415M MedTech Dive

Inari Medical agrees to buy LimFlow in $415m deal - Medical Device Network

Inari Medical agrees to buy LimFlow in $415m deal Medical Device Network

Novel System Snags FDA Approval for Severe Peripheral Arterial Disease - MedPage Today

Novel System Snags FDA Approval for Severe Peripheral Arterial Disease MedPage Today

Blood-clot buster Inari snatches up limb-saving implant maker LimFlow for $415M - Fierce Biotech

Blood-clot buster Inari snatches up limb-saving implant maker LimFlow for $415M Fierce Biotech

LimFlow announces agreement to be acquired by Inari Medical - Vascular News

LimFlow announces agreement to be acquired by Inari Medical Vascular News

How LimFlow’s foot-saving system prevents amputations in patients with no other options - Medical Design & Outsourcing

How LimFlow’s foot-saving system prevents amputations in patients with no other options Medical Design & Outsourcing

Henry Ford Health performs first commercial “limflow” patient procedure in Michigan - EurekAlert!

Henry Ford Health performs first commercial “limflow” patient procedure in Michigan EurekAlert!

FDA approves LimFlow chronic limb-threatening ischemia treatment - MassDevice

FDA approves LimFlow chronic limb-threatening ischemia treatment MassDevice

First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device - Diagnostic and Interventional Cardiology

First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device Diagnostic and Interventional Cardiology

LimFlow System a ‘cost-effective and high-value alternative’ to traditional therapies - Vascular News

LimFlow System a ‘cost-effective and high-value alternative’ to traditional therapies Vascular News

“Maybe we’re overthinking it” — A tough call was the right call for this medtech developer - Medical Design & Outsourcing

“Maybe we’re overthinking it” — A tough call was the right call for this medtech developer Medical Design & Outsourcing

Inari Medical closes $415M LimFlow acquisition - MassDevice

Inari Medical closes $415M LimFlow acquisition MassDevice

LimFlow Reports Positive Data in Pilot Study of Percutaneous Deep Vein Arterialization System - Diagnostic and Interventional Cardiology

LimFlow Reports Positive Data in Pilot Study of Percutaneous Deep Vein Arterialization System Diagnostic and Interventional Cardiology

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia - Diagnostic and Interventional Cardiology

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia Diagnostic and Interventional Cardiology

FDA approves LimFlow device that may reduce amputations; pivotal studies done at University Hospitals - WKYC

FDA approves LimFlow device that may reduce amputations; pivotal studies done at University Hospitals WKYC

After Inari deal, Limflow COO joins heart pump startup Brightflow as CEO - MassDevice

After Inari deal, Limflow COO joins heart pump startup Brightflow as CEO MassDevice

Medical device to rescue legs from amputation wins approval, then company is sold - The Business Journals

Medical device to rescue legs from amputation wins approval, then company is sold The Business Journals

Inari Medical to Acquire LimFlow for Up to $415M - Medical Product Outsourcing

Inari Medical to Acquire LimFlow for Up to $415M Medical Product Outsourcing

First CLTI patient enrolled in PROMISE II pivotal study of LimFlow system - Vascular News

First CLTI patient enrolled in PROMISE II pivotal study of LimFlow system Vascular News

Positive two-year data from ALPS registry of LimFlow system published - Venous News

Positive two-year data from ALPS registry of LimFlow system published Venous News

LimFlow completes enrolment in US feasibility study - Vascular News

LimFlow completes enrolment in US feasibility study Vascular News

LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia - MassDevice

LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia MassDevice

LimFlow taps Rose for CEO | Personnel Moves - MassDevice

LimFlow taps Rose for CEO | Personnel Moves MassDevice

Singapore’s M&L Healthcare sells treatment tech start-up for diabetes-related condition for $334m - The Straits Times

Singapore’s M&L Healthcare sells treatment tech start-up for diabetes-related condition for $334m The Straits Times

Top Limflow, Now Part Of Stryker Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant